Reyataz
Product Images NDC 69189-3624

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Reyataz (NDC 69189-3624). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avera Mckennan Hospital, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atazanavir 150 mg Capsule (6918936241)

Atazanavir (Reyataz) is a medication that comes in the form of 150 mg capsules. The other information present on the label includes a batch number (4A834335/C15D28—A), a serial number (6918936241 b), the manufacturer's name (E.R. SQUIBB), and an expiration date (3/31/1¢).*

FDA Label Image

Reyataz Chemical Structure (Image 01)

FDA Label Image

Reyataz Fig 1 (Reyataz Figure1)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.